Cargando…

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy

PURPOSE: The incidence of local prostate cancer recurrences after monotherapy with high-dose-rate brachytherapy (HDR-BT) is low. However, a cumulated number of local recurrences during follow-up is naturally observed in highly specialized oncological centers. This retrospective study aimed to presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burchardt, Wojciech M., Chyrek, Artur J., Bielęda, Grzegorz M., Kluska, Adam, Burchardt, Ewa, Chicheł, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196734/ https://www.ncbi.nlm.nih.gov/pubmed/37215611 http://dx.doi.org/10.5114/jcb.2023.126618

Ejemplares similares

Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
por: Burchardt, Wojciech, et al.
Publicado: (2019)

High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series
por: Chyrek, Artur J., et al.
Publicado: (2020)

Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection
por: Chyrek, Artur Jan, et al.
Publicado: (2019)

Thermal Boost Combined with Interstitial Brachytherapy in Early Breast Cancer Conserving Therapy—Initial Group Long-Term Clinical Results and Late Toxicity
por: Chicheł, Adam, et al.
Publicado: (2022)

Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study
por: Chyrek, Artur J., et al.
Publicado: (2022)

High-dose-rate surface brachytherapy as a treatment option for renal cell carcinoma cutaneous metastases
por: Raszewski, Łukasz, et al.
Publicado: (2021)

Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES
por: Chicheł, Adam, et al.
Publicado: (2023)

3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results
por: Bielęda, Grzegorz, et al.
Publicado: (2022)

Thermal Boost to Breast Tumor Bed—New Technique Description, Treatment Application and Example Clinical Results
por: Chicheł, Adam, et al.
Publicado: (2022)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

Dosimetric assessment of the impact of low-cost materials used in stereolithography in high-dose-rate brachytherapy
por: Bielęda, Grzegorz, et al.
Publicado: (2021)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review
por: Konat-Bąska, Katarzyna, et al.
Publicado: (2020)

Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
por: Nakiri, Makoto, et al.
Publicado: (2022)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy
por: Boussion, Nicolas, et al.
Publicado: (2021)

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
por: Cendales, Ricardo, et al.
Publicado: (2015)

Pulsed dose rate brachytherapy of lip cancer
por: Serkies, Krystyna, et al.
Publicado: (2013)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy
por: Chang, Lynn, et al.
Publicado: (2014)

Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy
por: Scherf, Christian, et al.
Publicado: (2022)

High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience
por: Soatti, Carlo Pietro, et al.
Publicado: (2020)

A Report on the Clinical Outcome after High-Dose Rate (HDR) Brachytherapy as Monotherapy in Early Prostate Cancer
por: Potharaju, Mahadev, et al.
Publicado: (2015)

High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021)

Personalized Superficial HDR Brachytherapy—Dosimetric Verification of Dose Distribution with Lead Shielding of Critical Organs in the Head and Neck Region
por: Zwierzchowski, Grzegorz, et al.
Publicado: (2022)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020)

High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina
por: Beriwal, Sushil, et al.
Publicado: (2008)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection
por: Salembier, Carl, et al.
Publicado: (2013)

Modification of Source Strength in Low-Dose-Rate Lung Brachytherapy with (125)I and (103)Pd Seeds
por: Rezaei, H., et al.
Publicado: (2017)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
por: Viani, Gustavo A, et al.
Publicado: (2009)

Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2014)

A radiobiological study of the schemes with a low number of fractions in high-dose-rate brachytherapy as monotherapy for prostate cancer
por: Guirado, Damián, et al.
Publicado: (2020)

Prevention of high-dose-rate brachytherapy accidents
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_0rcu76pehko78ds3rikrvp0v5p